Jiangsu CoWin Biotech Co., Ltd. (SHA:688426)
China flag China · Delayed Price · Currency is CNY
23.00
+0.49 (2.18%)
At close: Jul 24, 2025, 2:57 PM CST

Jiangsu CoWin Biotech Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019 - 2020
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2020
2,5283,1803,4293,314--
Upgrade
Market Cap Growth
-12.73%-7.26%3.44%---
Upgrade
Enterprise Value
1,9282,5762,2452,963--
Upgrade
Last Close Price
23.0028.6130.5529.10--
Upgrade
PE Ratio
---20.81--
Upgrade
Forward PE
-21.8021.80---
Upgrade
PS Ratio
18.0525.2620.016.35--
Upgrade
PB Ratio
1.732.142.041.85--
Upgrade
P/TBV Ratio
1.822.252.101.90--
Upgrade
P/FCF Ratio
---474.27--
Upgrade
P/OCF Ratio
---30.87--
Upgrade
EV/Sales Ratio
13.7620.4613.105.68--
Upgrade
EV/EBITDA Ratio
---15.62--
Upgrade
EV/EBIT Ratio
---16.80--
Upgrade
EV/FCF Ratio
-13.18--424.05--
Upgrade
Debt / Equity Ratio
0.020.020.020.020.07-
Upgrade
Debt / EBITDA Ratio
---0.200.27-
Upgrade
Debt / FCF Ratio
---5.841.99-
Upgrade
Asset Turnover
0.080.070.090.400.620.88
Upgrade
Inventory Turnover
1.611.611.603.773.342.52
Upgrade
Quick Ratio
9.679.2412.2916.796.5914.27
Upgrade
Current Ratio
11.419.9212.7817.467.2515.36
Upgrade
Return on Equity (ROE)
-9.95%-10.20%-4.83%14.58%26.16%45.05%
Upgrade
Return on Assets (ROA)
-6.75%-6.93%-4.61%8.47%14.95%27.43%
Upgrade
Return on Capital (ROIC)
-7.20%-7.38%-4.91%9.11%16.33%30.31%
Upgrade
Return on Capital Employed (ROCE)
---9.50%22.30%27.70%
Upgrade
Earnings Yield
-5.97%-4.94%-2.46%4.81%--
Upgrade
FCF Yield
-5.78%-5.08%-4.99%0.21%--
Upgrade
Dividend Yield
---1.49%--
Upgrade
Payout Ratio
-----30.12%
Upgrade
Buyback Yield / Dilution
-0.24%0.93%-21.20%-10.07%-20.59%-29.55%
Upgrade
Total Shareholder Return
-0.93%-21.20%-8.58%-20.59%-29.55%
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.